Using a new technology and computational method, researchers have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.

KAIST researchers have discovered a molecular switch that can revert cancer cells back to normal by capturing the critical ...

A discovery of how to target mutated proteins in tumors made a decade ago never matured into a surefire way of destroying ...

Brain metastases (BMs) are a devastating complication of cancer, occurring ten times more frequently than primary brain ...

A person with neuroblastoma, which occurs when developing nerve cells in children turn cancerous, has remained tumour-free ...

IntroductionHepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates. It arises from ...

Professor Kwang-Hyun Cho's research team has recently been highlighted for their work on developing an original technology ...

Cells have surface receptors called integrins that bind to repetitive domains present on the extracellular matrix (ECM) surrounding the cells, allowing them to grow and spread. A new study from the ...

Researchers at The Jackson Laboratory created an aging breast tissue atlas, revealing how genetic and molecular shifts may ...